These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3311865)

  • 21. A preliminary evaluation of the differences in the glycosylation of alpha-1-acid glycoprotein between individual liver diseases.
    Anderson N; Pollacchi A; Hayes P; Therapondos G; Newsome P; Boyter A; Smith K
    Biomed Chromatogr; 2002 Sep; 16(6):365-72. PubMed ID: 12228891
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro binding of propranolol and progesterone to native and desialylated human orosomucoid.
    Wong AK; Hsia JC
    Can J Biochem Cell Biol; 1983 Oct; 61(10):1114-6. PubMed ID: 6652563
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies of the sialylation and microheterogeneity of human serum alpha 1-acid glycoprotein in health and disease.
    Moule SK; Peak M; Thompson S; Turner GA
    Clin Chim Acta; 1987 Jul; 166(2-3):177-85. PubMed ID: 3621599
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of radioactive glucosamine in the perfused rat liver to prepare alpha 1-acid glycoprotein (orosomucoid) with 3H- or 14C-labelled sialic acid and N-acetylglucosamine residues.
    Aronson NN
    Biochem J; 1982 Apr; 203(1):141-8. PubMed ID: 7103933
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glycosylation of three molecular forms of human alpha 1-acid glycoprotein having different interactions with concanavalin A. Variations in the occurrence of di-, tri-, and tetraantennary glycans and the degree of sialylation.
    Bierhuizen MF; De Wit M; Govers CA; Ferwerda W; Koeleman C; Pos O; Van Dijk W
    Eur J Biochem; 1988 Aug; 175(2):387-94. PubMed ID: 3402460
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Usefulness of determining hepatic clearance of Tc-HEPIDA in the diagnosis and differential diagnosis of chronic diseases of the liver parenchyma].
    Kuydowicz J; Studniarek M; Wojciechowski A; Liniecki J
    Pol Tyg Lek; 1989 Apr 10-17; 44(15-16):358-60. PubMed ID: 2626353
    [No Abstract]   [Full Text] [Related]  

  • 27. Studies on the site of addition of sialic acid and glucosamine to rat alpha 1-acid glycoprotein.
    Jamieson JC
    Can J Biochem; 1977 Apr; 55(4):408-14. PubMed ID: 870150
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic accuracy of alpha(1)-acid glycoprotein fucosylation for liver cirrhosis in patients undergoing hepatic biopsy.
    Rydén I; Påhlsson P; Lindgren S
    Clin Chem; 2002 Dec; 48(12):2195-201. PubMed ID: 12446476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative study of alpha 1-acid glycoprotein molecular variants in ascitic fluid of cancer and non-cancer patients.
    Fujii M; Takahashi N; Hayashi H; Furusho T; Matsunaga K; Yoshikumi C
    Anticancer Res; 1988; 8(3):303-6. PubMed ID: 3389735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cholestyramine loading test to assess hepatic reserve for bile acid synthesis in patients with chronic liver diseases.
    Kuroki S; Naito T; Okamoto S; Sakai H; Yamashita H; Chijiiwa K; Tanaka M
    Gastroenterology; 1997 Apr; 112(4):1277-83. PubMed ID: 9098013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum binding of ketoconazole in health and disease.
    Martínez-Jordá R; Rodriguez-Sasiain JM; Suárez E; Calvo R
    Int J Clin Pharmacol Res; 1990; 10(5):271-6. PubMed ID: 2079384
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urinary hydroxyproline and hydroxylysine excretions in relation to hepatic hydroxyproline content in chronic liver disease.
    Yamada S; Aoto Y; Suou T; Hirayama C
    Clin Biochem; 1989 Oct; 22(5):389-93. PubMed ID: 2805342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation.
    Carpino G; Morini S; Ginanni Corradini S; Franchitto A; Merli M; Siciliano M; Gentili F; Onetti Muda A; Berloco P; Rossi M; Attili AF; Gaudio E
    Dig Liver Dis; 2005 May; 37(5):349-56. PubMed ID: 15843085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Binding of alfentanil to human alpha 1-acid glycoprotein, albumin and serum.
    Belpaire FM; Bogaert MG
    Int J Clin Pharmacol Ther Toxicol; 1991 Mar; 29(3):96-102. PubMed ID: 2071261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation and limitations of the lipid-associated sialic acid test for the detection of human cancer.
    Voigtmann R; Pokorny J; Meinshausen A
    Cancer; 1989 Dec; 64(11):2279-83. PubMed ID: 2804920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative and qualitative binding characteristics of disopyramide in serum from patients with decreased renal and hepatic function.
    Pedersen LE; Bonde J; Graudal NA; Backer NV; Hansen JE; Kampmann JP
    Br J Clin Pharmacol; 1987 Jan; 23(1):41-6. PubMed ID: 3814461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relation between raised concentrations of fucose, sialic acid, and acute phase proteins in serum from patients with cancer: choosing suitable serum glycoprotein markers.
    Turner GA; Skillen AW; Buamah P; Guthrie D; Welsh J; Harrison J; Kowalski A
    J Clin Pathol; 1985 May; 38(5):588-92. PubMed ID: 2582003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alterations of branching and differential expression of sialic acid on alpha-1-acid glycoprotein in human seminal plasma.
    Kratz E; Poland DC; van Dijk W; Katnik-Prastowska I
    Clin Chim Acta; 2003 May; 331(1-2):87-95. PubMed ID: 12691868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum free and bound sialic acid and alpha-1-acid glycoprotein in patients with laryngeal cancer.
    Uslu C; Taysi S; Akcay F; Sutbeyaz MY; Bakan N
    Ann Clin Lab Sci; 2003; 33(2):156-9. PubMed ID: 12817619
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics and protein binding of cefazolin and cephalothin in patients with cirrhosis.
    Ohashi K; Tsunoo M; Tsuneoka K
    J Antimicrob Chemother; 1986 Mar; 17(3):347-51. PubMed ID: 3700294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.